Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy-Reference-Cited by-同舟云学术

Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy

Published:2016-09-29 Issue:1 Volume:4 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Makani Vishruti,Zhang Bin,Han Heeoon,Yao Yuemang,Lassalas Pierrik,Lou Kevin,Paterson Ian,Lee Virginia M. Y.,Trojanowski John Q.,Ballatore Carlo,Smith Amos B.,Brunden Kurt R.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-016-0378-4.pdf

Reference47 articles.

1. Alonso AD, GrundkeIqbal I, Iqbal K. Abnormally phosphorylated-tau from Alzheimer-disease brain depolymerizes microtubules. Neurobiol Aging. 1994;15:S37.

2. Alonso AD, GrundkeIqbal I, Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med. 1996;2:783–7.

3. Arriagada PV, Growdon JH, Hedleywhyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimers disease. Neurology. 1992;42:631–9.

4. Ballatore C, Lee VMY, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci. 2007;8:663–72.

5. Barten DM, Fanara P, Andorfer C, Hoque N, Wong PYA, Husted KH, Cadelina GW, Decarr LB, Yang L, Liu V, et al. Hyperdynamic microtubules, cognitive deficits, and pathology Are improved in Tau transgenic mice with Low doses of the microtubule-stabilizing agent BMS-241027. J Neurosci. 2012;32:7137–45.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer’s Disease;Central Nervous System Agents in Medicinal Chemistry;2024-08

2. Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice;Journal of Alzheimer's Disease;2024-03-19

3. Effects of intranasal dantrolene nanoparticles on brain concentration and behavior in PS19 tau transgenic mice;2023-05-11

4. A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy;Science Translational Medicine;2023-04-12

5. Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders;Molecular Neurobiology;2022-12-23